Soiken Holdings Inc. (TSE:2385) signed a contract to acquire 58.6% stake in Nrl Pharma, Inc from Nobuko Ando, Hiroshi Koike, Jiro Yoshimura, Tatsuo Hoshino, Masao Hara and Kazuhiro Kaneko for approximately ¥500 million on May 19, 2017. Soiken Holdings will acquire 0.01 million shares of Nrl Pharma. The consideration will be allocated in full value by cash on hand. The transaction was resolved by the Board of Soiken Holdings on May 19, 2017. The transaction is expected to close on June 27, 217. Sumitomo Mitsui Banking Corporation acted as financial advisor for Soiken Holdings. Soiken Holdings Inc. (TSE:2385) completed the acquisition of 64.5% stake in Nrl Pharma, Inc from Nobuko Ando, Hiroshi Koike, Jiro Yoshimura, Tatsuo Hoshino, Masao Hara and Kazuhiro Kaneko for approximately ¥570 million on June 27, 2017. Under the revised terms of the transaction, Soiken Holdings Inc. will acquire 0.008 million shares of Nrl Pharma, Inc.